Bernd Arents retweeted
Today is #WorldMentalHealthDay. Help your patients recognize and manage Major Depressive Disorder with DynaMedex. m.ebsco.is/uhxVG #MentalHealth #Depression
Bernd Arents retweeted
This review outlines what is known about the causes of atopic dermatitis (AD), specifically including the OX40 ligand (OX40L)/OX40 signaling axis. This review also discusses new treatments being developed that target OX40 and OX40L for treatment of AD.
doi.org/10.1093/bjd/ljae230
Bernd Arents retweeted
The Dermatology Life Quality Index as the primary outcome in randomized clinical trials: a systematic review
doi.org/10.1093/bjd/ljae228
Bernd Arents retweeted
Proud to stand with our #EFACommunity at the #EADVCongress!
VMCE, our Members from the Netherlands, work to improve the lives of people with #atopiceczema #dermatitis through education, support and advocacy ➡️ vmce.nl
📌Let's connect at Patient Organisation Area – at Amsterdam, The Netherlands
Bernd Arents retweeted
On-going (every day), frequent & generous use of emollients / moisturisers form the basis of #eczema management. Dermatology ANP Sheila Ryan shows how to use and apply moisturisers in the below clip from her workshop on 'Atopic Eczema Emollient Therapy'. bit.ly/3XFZw4W
Bernd Arents retweeted
An amazing day for @IADPO, @unihh and @cardiffuni! Launching the new Patient-Reported Impact of Dermatological Diseases (PRIDD) measure follows 7+ yrs of scientific rigour and engagement of >5600 patients worldwide. So proud of our community! #EADV2024
🚨 Launch Alert from #EADV2024! 🚨
GlobalSkin has launched a major dermatology advancement: the Patient-Reported Impact of Dermatological Diseases (#PRIDD) measure! Learn more at Pridd.org and download the app today! 📲
#SkinMatters #SkinPatientVoice
Bernd Arents retweeted
It’s an exciting day for @IADPO! Following 7 yrs of development with 5600 patients worldwide, we are launching the new Patient-Reported Impact of Dermatological Diseases (PRIDD) measure at #EADVCongress! PRIDD.org
Bernd Arents retweeted
GlobalSkin Board & Staff are attending the EADV Congress in Amsterdam, Sept 25–28! We’re excited to connect with dermatologists, researchers, partners, and Members like each year.
For our full schedule at the congress, visit bit.ly/GSatEADV2024
#EADV2024 #GlobalSkin
Bernd Arents retweeted
#EczemaHerpeticum is a potentially serious #SkinInfection caused by the #HerpesSimplexVirus.
🦠
We created the #AtopicDermatitis Visual Guide so you can see images of #eczema and its related conditions: nationaleczema.org/visual-gu…
#GetEczemaWise
Bernd Arents retweeted
🗨️ Word of the day 💬
Emollients are safe and effective – a good skin care routine using emollients can soothe, moisturise and protect the skin, helping to reduce the number of eczema flares.
For more information on emollients visit ⤵️
bit.ly/3TG2BAN
Bernd Arents retweeted
Oral JAK inhibitors are a powerful option for treating moderate to severe atopic dermatitis, offering rapid relief. However, careful patient selection and regular monitoring are essential due to potential risks like infections and cardiovascular issues. Experts from the Intern...
Bernd Arents retweeted
Today is #AtopicEczemaDay!
Let’s have a look at what are the most pressing issues for patients and their opinions on what research should address.
#AtopicEczemaUnfiltered
#AtopicEczemaDay
Bernd Arents retweeted
We sincerely appreciate the generous support from Almirall for the International Eczema Council. Your partnership plays a vital role in helping us advance our mission to improve patient care by promoting global research, education, and innovative practices in the treatment of ...
Bernd Arents retweeted
Patients’ voices are of great importance in research!
Our patient board not only shapes our research by helping us understand & address the needs of people living with #Eczema, but also supports us in communicating results in an easy to understand manner.
#AtopicEczemaDay
Bernd Arents retweeted
Proud to see some #BIOMAP_IMI contributions at @ESDRorg this year by @drpaternoster, @huebenthal_cau, Ana Rebane & Zoltan Radai.
We are looking forward to a productive exchange on dermatological research.
#ESDR2024
Bernd Arents retweeted
On this episode of NEA's #podcast, Eczema Out Loud, Dr. Mamta Jhaveri gives us the best itch-fighting tips she's learned from her experience as a person with #eczema, an #eczemacaregiver and a #dermatologist.
Listen here: nationaleczema.org/podcast-i…
#GetEczemaWise
Bernd Arents retweeted
EURneffy adrenaline nasal spray approved for use in the EU healio.com/news/allergy-asth…
Bernd Arents retweeted
#eczema in Diverse Racial and Ethnic Groups - Variations in Epidemiology, Genetics, Clinical Presentation, and Treatment researchgate.net/publication…
Bernd Arents retweeted
Introducing IEC Councilor Dr. Sandipan Dhar, MBBS MD DNB FRCP (Edin.). Dr. Dhar is a distinguished professor and the head of the Department of Pediatric Dermatology at the Institute of Child Health in Kolkata, India. Since September 2022, he has been pivotal in establishing pe...




































